Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-23-004898

President and CEO gave up 12,744 shares (to pay taxes)

  • President and CEO acquired 31,249 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Culley Brian M President and CEO 2023-02-11 Option exercise +31,249 139,143 D: show line 1 in the form
Culley Brian M President and CEO 2023-02-11 Shares withheld for taxes −12,744 $1.35 $17,204 126,399 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Culley Brian M President and CEO 2023-02-11 Option exercise · Restricted Stock Units −31,249 93,748 D: show line 3 in the form
Loading xslF345X03/ownership.xml…